Syros Reports First Quarter 2019 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Syros Reports First Quarter 2019 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

Syros Pharmaceuticals (SYRS) Tops Q1 EPS by 8c, Revenues Beat

May 1, 2019 7:40 AM EDT

Syros Pharmaceuticals (NASDAQ: SYRS) reported Q1 EPS of ($0.49), $0.08 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $454 thousand versus the consensus estimate of $430 thousand.

Our first quarter accomplishments mark important progress against our strategic priorities for 2019, said Nancy Simonian, M.D., Chief Executive Officer of... More